IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0077269
(2002-02-16)
|
발명자
/ 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
8 인용 특허 :
5 |
초록
▼
A method for producing a foam surfactant, and foam product suitable for a combined bovine teat dip and teat wash comprises air pressurization of a surfactant solution containing a germicide, disinfectant, biocide, etc., passing the air-surfactant mixture through a flow or line mixer to a foam holdin
A method for producing a foam surfactant, and foam product suitable for a combined bovine teat dip and teat wash comprises air pressurization of a surfactant solution containing a germicide, disinfectant, biocide, etc., passing the air-surfactant mixture through a flow or line mixer to a foam holding cup adjacent the teat area and expanding the mixture to atmospheric in the holding cup to produce an adherent surfactant foam product with reduced run-off, which both protects and reduces infection of the teat, particularly at the teat canal and surrounding udder area.
대표청구항
▼
A method for producing a foam surfactant, and foam product suitable for a combined bovine teat dip and teat wash comprises air pressurization of a surfactant solution containing a germicide, disinfectant, biocide, etc., passing the air-surfactant mixture through a flow or line mixer to a foam holdin
A method for producing a foam surfactant, and foam product suitable for a combined bovine teat dip and teat wash comprises air pressurization of a surfactant solution containing a germicide, disinfectant, biocide, etc., passing the air-surfactant mixture through a flow or line mixer to a foam holding cup adjacent the teat area and expanding the mixture to atmospheric in the holding cup to produce an adherent surfactant foam product with reduced run-off, which both protects and reduces infection of the teat, particularly at the teat canal and surrounding udder area. et al., A role for CD95 ligand in preventing graft rejection, Nature, 377:630-632 (Oct. 19, 1995). Berke, et al., PEL's and the Perforin and Granzyme Independent Mechanism of CTL-Mediated Lysis, Immunological Reviews, 146:21-31 (Aug. 1995) (Abstract Only). Berke, Killing Mechanisms of Cytotoxic Lymphocytes, Curr. Opin Hematol, 4(1):32-40 (Jan., 1997). Berke, TheCTL's Kiss of Death, Cell, 81(1):9-12 (Apr. 7, 1995) (Abstract Only). Berkner, Development of Adenovirus Vectors for the Expression of Heterologous Genes, Biotecniques 6(7):616 (1988). Boise, et al., Receptors that regulate T-cell susceptibility to apoptotic cell death, Annals of the New York Academy of Sciences, 766:70-80 (Sep. 7, 1995) (Abstract Only). Boldin, et al., A Novel Protein that Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain, Journal of Biological Chemistry, 270(14):7795-8 (Apr. 7, 1995) (Abstract Only). Bolling, et al., The Time Course of CTLAIg Effect on Cardiac Allograft Rejection. Journal of Surgical Research, 63(1):320-323 (Jun., 1996) (Abstract Only). Bonomo, et al., Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells, 154(12):6602-11 (Jun. 15, 1994) (Abstract Only). Braun, et al., Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease, Journal of Experimental Medicine, 183(2):657-61 (Feb. 1, 1996) (Abstract Only). Brossart, et al., Selective Activation of Fas/Fas Ligand-Mediated Cytotoxicity by a Self Peptide, Journal of Experimental Medicine, 183(6):2449-58 (Jun. 1, 1996) (Abstract Only). Burmester, et al., Management of Early Inflammatory Arthritis. Intervention with Immunomodulatory Agents: Monoclonal Antibody Therapy, Baillieres Clinical Rheumatology, 6(2):415-34 (Jun. 1992) (Abstract Only). Bussing, et al., Induction of Apoptosis in Human Lymphocytes Treated with Viscum Album L. is Mediated by the Mistletoe Lectins, Cancer Letters, 99(1):59-72 (Jan. 19, 1996 (Abstract Only). Candinas, et al., T Cell Independence of Macrophage and Natural Killer Cell Infiltration, Cytokine Production, and Endothelial Activation During Delayed Xenograft Rejection, Transplantation, 62(12):1920-1927 (Dec. 27, 1996). Caspi, et al., Genetic Factors in Susceptibility and Resistance to Experimental Autoimmune Uveoretinitis, Current Eye Research, 11 Suppl:81-6 (1992) (Abstract Only). Chandler, et al. Transplant Rejection Mechanisms and Treatment, Arch Surg 128:279-283 (Mar., 1993) (Abstract Only). Chen, et al., Polyreactive Antigen-Binding B Cells in the Peripheral Circulation are IgD+ and B7-, European Journal of Immunology, 26(12):2916-2923 (Dec., 1996) (Abstract Only). Chmura, et al., Loss of Ceramide Production Confers Resistance to Radiation-Induced Apoptosis, Cancer Research, 57(7):1270-1275 (Apr. 1, 1997) (Abstract Only). Chu, et al., A Fas-Associated Protein Factor, FAF1, Potentiates Fas-Mediated Apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 92(25):11894-8 (Dec. 5, 1995) (Abstract Only). Cleary, et al., Opposing Roles of CD95 (Fas/APO-1) and CD40 in the Death and Rescue of Human Low Density Tonsillar B Cells, Journal of Immunology, 155(7):3329-37 (Oct. 1, 1995) (Abstract Only). Clement, et al., Fas and Tumor Necrosis Factor Receptor-Mediated Cell Death: Similarities and Distinctions, Journal of Experimental Medicine, 180(2):557-67 (Aug. 1, 1994) (Abstract Only). Cone, et al., High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range, Proc. Natl. Acad. Sci., 81:6349 (1984). Constantinescu, et al., Effects of the Angiotensin Converting Enzyme Inhibitor Captopril on Experimental Autoimmune Encephalomyelitis, Immunopharmacology and Immunotoxicology, 17(3):471-91 (Aug., 1995) (Abstract Only). Coppel, et al., Primary biliary cirrhosis: the molecule and the mimic, Immunological Reviews, 144:17-49 (Apr., 1995) (Abstract Only). Corcoran, et al., Feline Asthma Syndrome: a Retrospective Study of the Clinical Presentation in 29 Cats, Journal of Small Animal Practices, 36(11):481-488 (Nov., 1995). Cosman, A Family of Ligands for the TNF Receptor Superfamily, Stem Cells 12:440-455 (1994) (Abstract Only). Costagliola, et al., Recombinant Thyrotropin Receptor and the Induction of Autoimmune Thyroid Disease in BALB/c Mice: a New Animal Model, Endocrinology, 135(5):2150-9 (Nov., 1994) (Abstract Only). Daniel, et al., Activation and Activation-induced Death of Human Tonsillar B Cells and Burkitt Lymphoma Cells: Lack of CD95 (Fas/APO-1) Ligand Expression and Function, European Journal of Immunology 27(4):1029-34 (Apr., 1997) (Abstract Only). Denburg, et al., Nervous System Lupus: Pathogenesis and Rationale for Therapy, Scandinavian Journal of Rheumatology, 24(5):263-73 (1995) (Abstract Only). Diaz, et al., T-lymphocyte Lines Specific for Glutamic Acid Decarboxylase (GAD) the 64K Beta-Cell Antigen of IDDM, Diabetes 41(1):118-21 (Jan., 1992) (Abstract Only). Dong, et al., Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated Virus, Human Gene Therapy, 7(17):2101-2112 (Nov. 10, 1996) (Abstract Only). DreEke, et al., Impact of Natural Killer Cells and Macrophages on the Course of Acute Graft Rejection Following Allogeneic Heart Transplantation in the Rat, Transplantation Proceedings, 28(6):3259-3260 (Dec., 1996). Druilhe, et al., Fas-Mediated Apoptosis in Cultured Human Eosinophils, Blood, 87(7):2822-2830 (Apr. 1, 1996) (Abstract Only). Duncan, et al., Cultured Fibroblasts in Avian Scleroderma, an Autoimmune Fibrotic Disease, Display an Activated Phenotype, Journal of Autoimmunity 5(5):603-15 (Oct., 1992) (Abstract Only). During, et al., Adeno-Associated Virus Vectors for Gene Therapy of Neurodegenerative Disorders, Clinical Neuroscience, 3(5):292-300 (1995-96) (Abstract Only). Eck, et al., The Structure of Tumor Necrosis Factor-Δ at 2.6 A Resolution, The Journal of Biological Chemistry, 264(29):17595-17604 (Oct. 15, 1989). Eischen, et al., Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions, Blood, 90(3):935-943 (Aug. 1, 1997). Eischen, et al., Fc Receptor-Induced Expression of Fas Ligand on Activated NK Cells Facilitates Cell-Mediated Cytotoxicity and Subsequent Autocrine NK Cell Apoptosis, Journal of Immunology, 156(8):2693-9 (Apr. 15, 1996) (Abstract Only). Enari, et al., Apoptosis by a cytosolic extract from Fas-activated cells, Embo Journal, 14(21):5201-8 (Nov. 1, 1995) (Abstract Only). Enari, et al., Different Apoptic Pathways Mediated by Fas and the Tumor-Necrosis-Factor Receptor. Cytosolic Phospholipase A2 is not Involved in Fas-Mediated Apoptosis, European Journal of Biochemistry, 236(2):533-8 (Mar. 1, 1996) (Abstract Only). Enari, et al., Involvement of an ICE-like protease in Fas-mediated apoptosis, Nature, 375(6526):78-81 (May 4, 1995) (Abstract Only). Enari, et al., Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis, Nature, 380(6576):723-6 (Apr. 25, 1996) (Abstract Only). Esser, et al., Distinct T Cell Receptor Signaling Requirments for Perforin-or FasL-Mediated Cytotoxicity, Journal of Experimental Medicine, 183(4):1697-706 (Apr. 1, 1996) (Abstract Only). Estaquier, et al., Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists, Blood, 87(12):4959-66 (Jun. 15, 1996) (Abstract Only). Evans, An engineererd poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies, Nature 339:385-388 (Jun., 1989). Faull, et al., Inside-out Signaling through Integrins, Journal of the American Society of Nephrology, 7(8):1091-1097 (Aug., 1996) (Abstract Only).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.